BSE
NSE

NSE Prices delayed by 15 minutes ! Prices as on Jul 09, 2025

ABB India 5898 [ 0.99% ]
ACC 1990.6 [ 0.54% ]
Ambuja Cements 590.35 [ -0.20% ]
Asian Paints Ltd. 2498.9 [ 0.58% ]
Axis Bank Ltd. 1164.7 [ -0.06% ]
Bajaj Auto 8361 [ 0.26% ]
Bank of Baroda 241.13 [ 0.57% ]
Bharti Airtel 2019.7 [ -0.51% ]
Bharat Heavy Ele 262.05 [ 1.53% ]
Bharat Petroleum 348.5 [ -2.00% ]
Britannia Ind. 5882 [ 0.74% ]
Cipla 1491.7 [ 0.23% ]
Coal India 387.45 [ 1.20% ]
Colgate Palm. 2438.6 [ -0.51% ]
Dabur India 522.15 [ 1.76% ]
DLF Ltd. 829.65 [ -1.57% ]
Dr. Reddy's Labs 1269.4 [ -1.12% ]
GAIL (India) 185.03 [ -3.95% ]
Grasim Inds. 2797.9 [ -0.81% ]
HCL Technologies 1674 [ -2.00% ]
HDFC Bank 2011.2 [ 0.49% ]
Hero MotoCorp 4333.1 [ 0.76% ]
Hindustan Unilever L 2423.4 [ 1.28% ]
Hindalco Indus. 673.95 [ -1.70% ]
ICICI Bank 1431.9 [ -0.70% ]
Indian Hotels Co 750.15 [ 1.47% ]
IndusInd Bank 840.75 [ -1.12% ]
Infosys L 1633.7 [ -0.31% ]
ITC Ltd. 419.45 [ 0.54% ]
Jindal St & Pwr 944.8 [ -0.66% ]
Kotak Mahindra Bank 2229.3 [ 0.22% ]
L&T 3579.7 [ -0.74% ]
Lupin Ltd. 1914.2 [ -0.41% ]
Mahi. & Mahi 3176.3 [ 0.58% ]
Maruti Suzuki India 12470 [ 0.45% ]
MTNL 49.5 [ 0.24% ]
Nestle India 2427.8 [ 0.41% ]
NIIT Ltd. 127.9 [ 1.92% ]
NMDC Ltd. 67.9 [ -0.57% ]
NTPC 344 [ 0.23% ]
ONGC 243.35 [ 0.05% ]
Punj. NationlBak 111 [ -0.90% ]
Power Grid Corpo 299.65 [ 0.64% ]
Reliance Inds. 1519 [ -1.21% ]
SBI 810.95 [ -0.21% ]
Vedanta 440.75 [ -3.41% ]
Shipping Corpn. 224.83 [ -0.45% ]
Sun Pharma. 1669.4 [ -0.19% ]
Tata Chemicals 922.35 [ -0.38% ]
Tata Consumer Produc 1097.9 [ -0.18% ]
Tata Motors 692.8 [ -0.06% ]
Tata Steel 159 [ -1.83% ]
Tata Power Co. 400.65 [ -0.05% ]
Tata Consultancy 3383.8 [ -0.66% ]
Tech Mahindra 1614.8 [ -1.26% ]
UltraTech Cement 12562 [ 0.94% ]
United Spirits 1370.9 [ 0.45% ]
Wipro 267.8 [ -0.69% ]
Zee Entertainment En 141.79 [ -2.78% ]

Partner with US

Open an Demat Account

Portfolio Tracker

News Details
Home

News Details

01/07/2025 12:13

Back

Accretion Pharma - Clarification - Financial Results

The Exchange has sought clarification from Accretion Pharmaceuticals Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI -2. The company has not submitted declaration in case of unmodified opinion(s) The response of the Company is awaited.